{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:43:04Z","timestamp":1789728184342,"version":"4.0.1"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T00:00:00Z","timestamp":1417651200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0003322","type":"journal-article","created":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T19:37:20Z","timestamp":1417721840000},"page":"e3322","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["HSP70 Domain II of Mycobacterium tuberculosis Modulates Immune Response and Protective Potential of F1 and LcrV Antigens of Yersinia pestis in a Mouse Model"],"prefix":"10.1371","volume":"8","author":[{"given":"Lalit","family":"Batra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra K.","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durgesh P.","family":"Nagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandita","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachi","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish C.","family":"Pant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urmil","family":"Tuteja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,12,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Sherman IW (2007) Twelve diseases that changed our world. Washington DC: ASM Press: 68.","DOI":"10.1128\/9781555816346.ch5"},{"key":"ref2","first-page":"662","article-title":"La peste bubonique a&apos; Hong-Kong","volume":"8","author":"A Yersin","year":"1894","journal-title":"Ann Inst Pasteur"},{"key":"ref3","first-page":"338","article-title":"Human plague in 1998 and 1999","volume":"75","year":"2000","journal-title":"Wkly Epidemiol Rec"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"<italic>Yersinia pestis<\/italic> etiologic agent of plague","volume":"10","author":"RD Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0140-6736(07)60566-2","article-title":"Plague","volume":"369","author":"MB Prentice","year":"2007","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e1004029","DOI":"10.1371\/journal.ppat.1004029","article-title":"New insights into how <italic>Yersinia pestis<\/italic> adapts to its mammalian host during bubonic plague","volume":"10","author":"E Pradel","year":"2014","journal-title":"PLoS Pathog"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"283","author":"TV Inglesby","year":"2000","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199709043371004","article-title":"Multidrug resistance in <italic>Yersinia pestis<\/italic> mediated by a transferable plasmid","volume":"337","author":"M Galimand","year":"1997","journal-title":"N Eng J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3201\/eid0701.010106","article-title":"Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of <italic>Yersinia pestis<\/italic>","volume":"7","author":"A Guiyoule","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/vbz.2011.0748","article-title":"Phenotypical characterization of Mongolian <italic>Yersinia pestis<\/italic> strains","volume":"12","author":"D Kiefer","year":"2012","journal-title":"Vector Borne Zoonotic Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0264-410X(95)00090-N","article-title":"A comparison of plague vaccine, USP and EV76 vaccine induced protection against <italic>Yersinia pestis<\/italic> in a murine model","volume":"13","author":"P Russell","year":"1995","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1128\/IAI.00273-09","article-title":"D27-pLpxL, an avirulent strain of <italic>Yersinia pestis<\/italic>, primes T cells that protect against pneumonic plague","volume":"77","author":"FM Szaba","year":"2009","journal-title":"Infect Immun"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1586\/erv.09.129","article-title":"Prospects for new plague vaccines","volume":"8","author":"VA Feodorova","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1093\/infdis\/129.Supplement_1.S13","article-title":"Plague immunization. I. Past and present trends","volume":"129","author":"KF Meyer","year":"1974","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/S0264-410X(02)00119-6","article-title":"Determination of the virulence of the pigmentation deficient and pigmentation-\/plasminogen activator-deficient strains of <italic>Yersinia pestis<\/italic> in non-human primate and mouse models of pneumonic plague","volume":"20","author":"S Welkos","year":"2002","journal-title":"Vaccine"},{"key":"ref16","first-page":"209","article-title":"Current challenges in the development of vaccines for pneumonic plague Expert Rev Vaccines","volume":"7","author":"ST Smiley","year":"2008"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1128\/CVI.00398-06","article-title":"Development of in vitro correlate assays of immunity to infection with <italic>Yersinia pestis<\/italic>","volume":"14","author":"J Bashaw","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"897","DOI":"10.4049\/jimmunol.1100174","article-title":"<italic>Yersinia pestis<\/italic> YopE contains a dominant CD8 T cell epitope that confers protection in a mouse model of pneumonic plague","volume":"187","author":"JS Lin","year":"2011","journal-title":"J Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1128\/IAI.01860-05","article-title":"Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV","volume":"74","author":"KL DeBord","year":"2006","journal-title":"Infect Immun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.vaccine.2009.02.016","article-title":"CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague","volume":"27","author":"K Amemiya","year":"2009","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/IAI.74.2.1113-1120.2006","article-title":"Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with <italic>Yersinia pestis<\/italic>","volume":"74","author":"AN Honko","year":"2006","journal-title":"Infect Immun"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1086\/507644","article-title":"Protective immunity against respiratory tract challenge with <italic>Yersinia pestis<\/italic> in mice immunized with an adenovirus-based vaccine vector expressing V antigen","volume":"194","author":"MJ Chiuchiolo","year":"2006","journal-title":"J Infect Dis"},{"key":"ref23","first-page":"813","article-title":"Development of <italic>Yersinia pestis<\/italic> F1 antigen-loaded microspheres vaccine against plague","volume":"9","author":"SS Huang","year":"2014","journal-title":"Int J Nanomedicine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1093\/clinids\/21.Supplement_2.S178","article-title":"Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of <italic>Yersinia pestis<\/italic>","volume":"21","author":"AM Friedlander","year":"1995","journal-title":"Clin Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1128\/IAI.65.2.446-451.1997","article-title":"Passive immunity to infection with <italic>Yersinia<\/italic> spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen","volume":"65","author":"A Roggenkamp","year":"1997","journal-title":"Infect Immun"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1038\/emi.2012.34","article-title":"Plague vaccines: current developments and future perspectives","volume":"1","author":"AF Valentina","year":"2012","journal-title":"Emerg Microb Infect"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.micpath.2004.06.009","article-title":"Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague","volume":"37","author":"SJ Elvin","year":"2004","journal-title":"Microb Pathog"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1600-065X.2008.00674.x","article-title":"Immune defense against pneumonic plague","volume":"225","author":"ST Smiley","year":"2008","journal-title":"Immunol Rev"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.vaccine.2010.08.099","article-title":"TNF-\u03b1 and IFN-\u03b3 contribute to F1\/LcrV targeted immune defense in mouse models of fully virulent pneumonic plague","volume":"29","author":"JS Lin","year":"2010","journal-title":"Vaccine"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"873","DOI":"10.4049\/jimmunol.156.2.873","article-title":"Adjuvant-free HSP70(II) fusion protein system elicits humoral and cellular responses to HIV-1 p24","volume":"156","author":"K Suzue","year":"1996","journal-title":"J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"13146","DOI":"10.1073\/pnas.94.24.13146","article-title":"Heat shock protein fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway","volume":"94","author":"K Suzue","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1016\/S0264-410X(00)00492-8","article-title":"Heat shock proteins: the \u2018Swiss army knife\u2019 vaccines against cancers and infectious agents","volume":"19","author":"PK Srivastava","year":"2001","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(03)14075-5","article-title":"Heat shock proteins as regulators of the immune response","volume":"362","author":"AG Pockley","year":"2003","journal-title":"Lancet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0145-305X(02)00160-X","article-title":"Evolution of heat shock protein and immunity","volume":"27","author":"J Robert","year":"2003","journal-title":"Dev Comp Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1046-2023(03)00136-1","article-title":"Augmentation of DNA vaccine potency through secretory heat shock protein-mediated antigen targeting","volume":"31","author":"H Hauser","year":"2003","journal-title":"Methods"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1084\/jem.191.2.403","article-title":"In vivo cytotoxic T lymphocyte elicitation by mycobacterial heat shock protein 70 fusion proteins maps to a discrete domain and is CD4+ T cell independent","volume":"191","author":"Q Huang","year":"2000","journal-title":"J Exp Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1016\/j.vaccine.2006.03.030","article-title":"A synthetic dengue virus antigen elicits enhanced antibody titers when linked to, but not mixed with, Mycobacterium tuberculosis HSP70 domain II","volume":"24","author":"R Kolli","year":"2206","journal-title":"Vaccine"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/346623a0","article-title":"Three-dimensional structure of the ATPase fragment of a 70K heat-shock cognate protein","volume":"346","author":"KM Flaherty","year":"1990","journal-title":"Nature"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3201\/eid1304.051105","article-title":"Pneumonic Plague, Northern India, 2002","volume":"13","author":"ML Gupta","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"ref40","first-page":"151","article-title":"Characterization of immune responses to <italic>Yersinia pestis<\/italic> (Indian isolate) infection in mouse model","volume":"4","author":"SK Verma","year":"2013","journal-title":"J Clin Cell Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.2174\/092986609789353709","article-title":"Antibodies against refolded recombinant envelope protein (domain III) of Japanese encephalitis virus inhibit the JEV infection to porcine stable kidney cells","volume":"16","author":"SK Verma","year":"2009","journal-title":"Protein Peptide Lett"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"MM Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1016\/j.vaccine.2009.09.006","article-title":"Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in Balb\/C mice","volume":"27","author":"SK Verma","year":"2009","journal-title":"Vaccine"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jat.1114","article-title":"Evaluation of analogues of DRDE-07 as prophylactic agents against the lethality and toxicity of sulfur mustard administered through percutaneous route","volume":"26","author":"AS Kulkarni","year":"2006","journal-title":"J Appl Toxicol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/295407a0","article-title":"Co-occurrence of substance P-like and Leu-enkephalin-like immunoreactivities in neurones and fibres of avian nervous system","volume":"295","author":"JT Erichsen","year":"1982","journal-title":"Nature"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12044","article-title":"Protecting against plague: towards a next-generation vaccine","volume":"172","author":"ED Williamson","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"ref47","first-page":"56","article-title":"Plague in: vaccines for biodefense, supplement to vaccine","volume":"27","author":"ED Williamson","year":"2009","journal-title":"Vaccine"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1128\/IAI.01595-13","article-title":"Deletion of Braun Lipoprotein and Plasminogen-Activating Protease-Encoding Genes Attenuates <italic>Yersinia pestis<\/italic> in Mouse Models of Bubonic and Pneumonic Plague","volume":"82","author":"CJ Vanlier","year":"2014","journal-title":"Infect Immun"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1128\/IAI.73.11.7304-7310.2005","article-title":"Cell-mediated protection against pulmonary <italic>Yersinia pestis<\/italic> infection","volume":"73","author":"MA Parent","year":"2005","journal-title":"Infect Immun"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1286-4579(00)01359-9","article-title":"TNF-alpha and IL-12: a balancing act in macrophage functioning","volume":"3","author":"X Ma","year":"2001","journal-title":"Microbes Infect"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"K Schroder","year":"2004","journal-title":"J Leukoc Biol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1128\/IAI.01517-07","article-title":"Interaction between <italic>Yersinia pestis<\/italic> and the host immune system","volume":"76","author":"B Li","year":"2008","journal-title":"Infect Immun"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.micpath.2004.06.009","article-title":"Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague","volume":"37","author":"SJ Elvin","year":"2004","journal-title":"Microb Pathog"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1128\/IAI.00185-06","article-title":"Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary <italic>Yersinia pestis<\/italic> infection","volume":"74","author":"MA Parent","year":"2006","journal-title":"Infect Immun"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1128\/IAI.66.1.347-352.1998","article-title":"Characterization of the immunostimulatory properties of <italic>Leishmania infantum<\/italic> HSP70(II) by fusion to the <italic>Escherichia coli<\/italic> maltose binding protein in normal and <italic>nu\/nu<\/italic> Balb\/C mice","volume":"66","author":"AI Rico","year":"1998","journal-title":"Infect Immun"},{"key":"ref56","first-page":"1035","article-title":"Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70(II) gene","volume":"60","author":"CH Chen","year":"2000","journal-title":"Cancer Res"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nri778","article-title":"Effector and memory T-cell differentiation: implications for vaccine development","volume":"2","author":"SM Kaech","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1128\/IAI.71.7.3673-3681.2003","article-title":"Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen)","volume":"71","author":"RR Brubaker","year":"2003","journal-title":"Infect Immun"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1574-695X.1995.tb00196.x","article-title":"A new improved sub-unit vaccine for plague: the basis of protection","volume":"12","author":"ED Williamson","year":"1995","journal-title":"FEMS Immunol Med Microbiol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4269\/ajtmh.1998.58.793","article-title":"Short- and long-term efficacy of single-dose subunit vaccines against <italic>Yersinia pestis<\/italic> in mice","volume":"58","author":"GW Anderson Jr","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"DG Heath","year":"1998","journal-title":"Vaccine"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1016\/j.vaccine.2011.04.084","article-title":"Recombinant (F1+V) vaccine protects macaques against pneumonic plague","volume":"29","author":"ED Williamson","year":"2011","journal-title":"Vaccine"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/CVI.00333-08","article-title":"Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates","volume":"16","author":"SB Mizel","year":"2009","journal-title":"Clin Vaccine Immunol"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0012406","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"record-id":"55656"},{"DOI":"10.1371\/journal.pntd.0012406","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000}}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0003322","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T12:58:51Z","timestamp":1690721931000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0003322"}},"subtitle":[],"editor":[{"given":"Mary Ann","family":"McDowell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,4]]},"references-count":63,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0003322","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,4]]}}}